GUMC finds possible new treatment for those with type 1 diabetes
This past weekend at the American Society of Cell Biology annual meeting researchers from Georgetown University Medical Center presented research that may change the treatment for people with type 1 diabetes.
Dr. Ian Gallicano, associate professor of cell biology and director of the transgenic core facility, led the study that found a way to create insulin in patients with type 1 diabetes.
Gallicano nurtured spermatogonial stem cells in the lab to create pancreatic beta cells. These cells eventually produced insulin.
People with type 1 diabetes, which is also known as juvenile onset diabetes, currently must take insulin for the entirety of their lives.
With this procedure, men with type 1 would likely be able to create their own transplants.
“While these cells come from the human testis, the work here is not necessarily male-centric,” Gallicano wrote in the research paper, noting that there is the possibility that similar procedures could be discovered for women.
The effect of the research on mice yielded results that lasted for about a week, but newer research has shown longer effects, which Gallicano believes can be exponentially increased.